Skip to main content
Apyx Medical Corp logo

Apyx Medical Corp — Investor Relations & Filings

Ticker · APYX ISIN · US0323472052 LEI · 5299009QZVYUYO082S45 US Manufacturing
Open in API
Filings indexed 969 across all filing types
Latest filing 2018-05-14 Earnings Release
Country US United States of America
Listing US APYX

About Apyx Medical Corp

https://apyxmedical.com/

Apyx Medical Corporation is an advanced energy technology company that develops, manufactures, and markets innovative products for surgical and cosmetic markets. The company's proprietary Helium Plasma Platform, which is the foundation for its Renuvion® and J-Plasma® brands, utilizes a unique combination of helium plasma and radiofrequency (RF) energy. These systems are designed to deliver controlled energy for the cutting, coagulation, and ablation of soft tissue, with a primary focus on aesthetic procedures for skin tightening and body contouring. Apyx Medical, formerly Bovie Medical, leverages its expertise in energy-based waveforms to provide transformative solutions for surgeons and their patients.

Recent filings

Filing Released Lang Actions
BVX_8-K_2018.05.14
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated May 14, 2018, reporting the results of operations for the first fiscal quarter ended March 31, 2018. It references a press release attached as Exhibit 99.1 that contains the earnings release information. The document itself is short (3278 characters) and primarily serves to announce the earnings release rather than provide detailed financial statements or analysis. According to the rules, such a document is classified as an Earnings Release (ER) because it is the initial announcement of quarterly financial results with key highlights, not a full interim report or annual report.
2018-05-14 English
Regulatory Filings 2018
Regulatory Filings Classification · 90% confidence The document text appears to be a large block of encoded or compressed data, possibly a binary or PDF file content encoded in ASCII. There are no readable keywords, regulatory headers, form names, fiscal period dates, or document titles visible in the provided text. The length is 15,000 characters, which is substantial, but the content does not contain any discernible financial data, report titles, or announcements. Given the lack of identifiable information and the nature of the content, the best classification is Regulatory Filings (RNS) as a fallback category for miscellaneous filings that do not fit other specific categories.
2018-05-09 English
BVX_2018.05_S-3
Capital/Financing Update Classification · 100% confidence The document is a Form S-3 Registration Statement filed with the SEC under the Securities Act of 1933. It is a registration statement for the offering of securities including common stock, preferred stock, debt securities, warrants, and units, with a maximum aggregate offering price of $25,000,000. The document includes detailed information about the securities to be offered, the plan of distribution, risk factors, and legal matters. It is not a financial report, earnings release, or management discussion, but rather a capital raising filing. Therefore, it fits the category of Capital/Financing Update filings, which cover updates on company fundraising and financing activities.
2018-05-04 English
BVX_2018.05.03_8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content specifically discusses the filing of a Certificate of Elimination related to the company's Series A and Series B Convertible Preferred Stock, which is an amendment to the company's articles of incorporation. This type of filing is not a full annual or quarterly report, nor is it an earnings release or management discussion. It is a regulatory announcement about a corporate structural change. Given the nature of the content and the form type (8-K), this fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories. The document length is short (3594 characters), and it contains substantive information about the corporate action, not just a notice of report publication or certification. Therefore, the classification is RNS with high confidence.
2018-05-03 English
FORM 3
Director's Dealing
2018-04-11 English
BVX_8-K_2018.03.14
Board/Management Information Classification · 100% confidence The document is a Form 8-K filing with the SEC, dated March 14, 2018, reporting the appointment of a new director and member of the audit committee. The key section is Item 5.02, which specifically addresses the departure or appointment of directors or certain officers. There is no financial data or report content, only an announcement of a management change. Therefore, this document fits the category of Board/Management Information (MANG). The document length is 4089 characters, which is consistent with a typical 8-K announcement rather than a full report.
2018-03-14 English

Browse filings by year

32 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.